Today, with over 100 chapters in more than 20 countries across the world, UAEM students work to influence policies at universities in order to ensure that products of biomedical research and development are made available to and affordable to the people who need them most. Historically this has been the poor and most marginalized worldwide.
The current biomedical Research and Development (R&D) system serves profits over people. Despite the global crisis of high drug prices, R&D investments continue to focus on medicines that can be sold at high prices leaving much needed medicines undeveloped and existing lifesaving medicines often too expensive for those who need them most.
In the last 15 years, various R&D initiatives have appeared in response to this failure. Some offer true alternative models for biomedical R&D driven by health needs, while others continue with business as usual. UAEM’s RE:Route mapping provides a qualitative review of the alternative biomedical R&D initiatives around the world that are active or proposed. While this mapping covers a significant number of potential alternatives, it is evident that the need for fundamental change is as urgent as ever and universities can play a key role. Join us in bringing this dialogue forward!
Global Access Licensing: Report Cards Campaigns
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.